World-wide distribution of hepatitis C virus;L'infection par le virus de l'hépatite C dans le monde: Importance en santé publique, modes de transmission et perspectives

Virologie

Volumn 7, Issue 3, 2003, Pages 177-191

  Desenclos, J C ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Epidemiology; Hepatitis C virus; Public health

Indexed keywords

AFRICA; ASIA; BLOOD TRANSFUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG USE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION CONTROL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LIVER DISEASE; NORTH AMERICA; PLAGUE; PREVALENCE; PRIMARY PREVENTION; PUBLIC HEALTH; REVIEW; SOUTH AND CENTRAL AMERICA; VIRUS TRANSMISSION; WESTERN EUROPE;

HEPATITIS C VIRUS;

EID: 0038104243     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Desenclos JC. Epidémiologie de l'hépatite C. Rev Prat 2000; 50: 1066-70.
2. Naoumov NV. Hepatitis C virus infection in Eastern Europe. J Hepatol 1999; 31: S84-7.
3. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999; 77: 789-800.
4. Trinchet JC. Histoire naturelle de l'infection par le virus de l'hépatite C. Gastroenterol Clin Biol 2002; 26: 144-53.
5. Freeman AJ, Dore Gj, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809-16.
6. Conférence de consensus sur l'hépatite C. Paris, 27-28 février 2002. Gastroenterol Clin Biol 2002; 26: B320-11.
7. Organisation mondiale de la Santé. Hépatite C: prévalence mondiale. Rel Epidémiol Hebd 1999; 74: 421-28.
8. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet 2003; 361: 1035-44.
9. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta analysis. Clin Inf Dis 2001; 33: 562-9.
10. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population based survey, 1994, distribution and risk factors. Hepatology 1997; 25: 1490-6.
11. Wasley AM, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16.
12. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36: S106-13.
13. Ruiz-Extremera A, Salmeron J, Torres C, et al. Follow up of hepatitis C to babies of human immunodeficiency virus - negative women: the role of breast-feeding in transmission. Pediatr Infect Sis J 2000; 19: 511-16.
14. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36: S99-S105.
15. Emmanuelli J, Jauffret-Roustide, Laporte A. Comportements face aux risques et prévalence VIH-VHB-VHC chez les usagers de drogues, Marseille, 2002. Journées scientifiques de l'InVS, Paris, 3 et 4 septembre 2002.
16. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 1999; 77: 801-07.
17. Frank C, Mohamed MK, Strickland GT. The role of parenteral anti-schistosomal therapy in the spread of hepatitis C in Egypt. Lancet 2000; 355: 877-91.
18. Mohamed MK, Aoun EA. Epidemiology, prevention and control programs of hepatitis C in Egypt. Who informal consultation with VHPB, Geneva, Switzerland, 13-14 May, 2002. http://www.vhpb.org/ geneva2002/S5BP1%20Mohamed.ppt.
19. Nicot T, Rogez S, Denis F. Epidémiologie de l'hépatite C en Afrique. Gastroenterol Clin Biol 1997; 21: 596-06.
20. Debonne JM, Nicand E, Boutin JP, Carre D, Buisson Y. L'hépatite C sous les tropiques. Méd Trop 1999; 59: 508-16.
21. Wiley TE, Brown J, Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol 2002; 97: 700-6.
22. Mallat DB, Jeffers L. The natural history of HCV infection in African American. Am J Gastroenterol 2002; 97: 520-2.
23. Dev AT, McCaw R, Sundararajan V, Bowden Sievert W. Southeast Asian patients with chronic hepatitis C infection: impact of novel genotypes and race on treatment. Hepatology 2002; 36: 1259-65.
24. Denis F, Aussel L, Ranger S, et al. Prevalence of antibodies to hepatitis C virus among patients with leprosy in several African countries and the Yemen. J Med Virol 1994; 43: 1-4.0
25. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2: 293-302.
26. Hayashi J, Kishihara Y, Yamaja K, et al. Transmission of hepatitis C by health care workers in a rural area of Japan. Am J Gastroenterol 1995; 90: 784-9.
27. Osella AR, Sonzogni L, Cavallini A, et al. Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study. J Clin Microbiol 1999; 37: 2371-2.
28. Nalpas B, Desenclos JC, Delarocque E, Drucker J. State of epidemiological knowledge and national management of hepatitis C virus infection in the european community. Eur J Pub Health 1998; 8: 305-12.
29. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000; 182: 698-707.
30. Gouezel P, Salmon D, Pialloux G, Holstein J, Delarocque-Astagneau E. Co-inf VIH-VHC à l'hôpital: enquête nationale 2001. InVS, Collection Enquêtes - Etudes, avril 2002.
31. Laurent C, Henzel D, Mulanga-Kabeya C, Maertens G, Larouze B, Delaporte E. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasha, Democratic republic of Congo. Int J Epidemiol 2001; 30: 872-7.
32. Delevoux M, Meunard D, Delaporte E. Low rate of hepatitis C virus antibodies in blood donors and pregnant women from Niger. Trans R Soc Trop Med Hygiene 1992; 86: 553.
33. Tess BH, Levin A, Brubaker G, et al. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. Am J Trop Med Hyg 2000; 62: 138-41.
34. Delevoux M, Meynard D, Dupont A, Delaporte E. Hepatitis C virus antibodies in prostitutes in Niger. Trans R Soc Trop Med Hygiene 1994; 88: 536.
35. Laosombat V, Pornpatkul M, Wongchanchailert M, Worachat K, Wiriyasatienku A. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand. Southeast Asian J Trop Med Pub Health 1997; 28: 149-53.
36. Carmo RA, Oliveira GC, Guimaraes MD, et al. Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study. Braz J Med Biol Res 2002; 35: 589-98.
37. Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi Med J 2002; 4: 393-5.
38. Hansurabhanon T, Jiraphongsa C, Tunsakun P et al. Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand. Ann Trop Med Parasitol 2002; 96: 615-25.
39. Thuring EG, Joller-Jemelka HI, Sareth H, Sokhan U, Reth C, Grob, P. Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province. Southeast Asean J Trop Med Pub Health 1993; 24: 239-249.
40. Chen TZ, Wu JC, Yen FS, et al. Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Medical Virol 1995; 46: 247-51.
41. Chang SJ, Chen HC, Ying J, Lu CF, Ko YC. Risk factors of hepatitis C virus infection in a Taiwanese aboriginal community. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1996; 12: 241-7.
42. Mohamed MK, Hussein MH, Massoud AA et al. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad. J Egypt Pub Health Assoc 1996; 71: 113-42.
43. Ho M-S, Hsu CP, Yuh Y, et al. High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena? J Med Virol 1997; 52: 370-6.
44. Luby SP, Qamruddin K, Shah AA, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997; 119: 349-56.
45. El-Sakka, H. Risk factors for HCV infection. Gharbia Governorate, Egypt, 1996-7. Presentation given at the EIS conference, Atlanta, GA, USA., April 1997.
46. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999; 59: 290-6.
47. Khan AJ, Luby SP, Fikree FF, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000; 78: 956-63.
48. Sun CA, Chen HC, Lu SN, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001; 65: 30-4.
49. Hauri A, Amstrong GL, Hutin YJF. Contaminated injections in health care setting. In: comparative quantification of health risks: global and regional burden of disease attributable to selective major risk factors. Ezzati M, Lopez AD, Rodgers A, Murray CJL editors. WHO, Geneva, 2003.
50. Bogach VV, Starostina IS, Trotsenko, et al. The prevalence of hepatitis B and C markers among narcotic users in Russia. Zh Mikrobiol Epidemiol Immunobiol 2000; 4: 46-9.
51. Caplinskas S, Griskevicius A, Likatavicius G. The prevalence of viral hepatitis among youth in Lithuania. Zh Mikrobiol Epidemiol Immunobiol 2000; 4: 53-4.
52. Osztrogonacz H, Gerevich J, Horvath G, Tolvaj G, David K. Prevalence of chronic viral hepatitis in drug abusers in Hungary. Orv Hetil 2000; 141: 715-8.
53. Abdourakhmanov DT, Hasaev AS, Castro FJ, Guardia J. Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Dhaghestan. Eur J Epidemiol 1998; 14: 549-53.
54. Karapetyan AF, Sokolovsky YV, Araviyskaya ER, Zvartau EE, Ostovsky DV, Hagan H. Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. Int J STD Aids 2002; 13: 618-23.
55. Kuzin SN, Lisitsina EV, Samokhavalov EI, et al. Spread of hepatitis C and separate genotypes of hepatitis C virus in a region with a moderately active epidemic process. Vopr Virusol 1999; 44: 79-82.
56. Tyczynska-Hoffmann B, Szklarska-Szczepanik A, Swincow G, et al. Hepatitis C virus infection in hospitalized children. Med Sci Monit 2000; 6: 361-4.
57. Vladutiu DS, Cosa A, Neamtu A, et al. Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map. J Viral Hepat 2000; 7: 313-9.
58. Sikorska K, Maniec M, Buraczewska A, Hlebowicz M, Keller A, Majewska K. Iatrogenic hepatitis B, non-A non-B, and C virus infections acquired in health service institutions of the Gdansk province, Poland. Przegl Epidemiol 1997; 51: 229-37.
59. Haukenes G, Brinchmann-Hansen K, Macovei O. Prevalence of hepatitis B and C and HIV antibodies in children in a Romanian orphanage. APMIS 1992; 100: 757-61.
60. Polz MA, Rajtar B, Daniluk J, Kowalczyk J, Ksiazek A, Pokora J. Infection with hepatitis C in patients hospitalized for various causes. Prevalence of anti-HCV antibodies in selected groups of patients. Przegl Epidemiol 1995; 49: 313-6.
61. Styczynski J, Wysocki M, Koltan S, Kurylak A. Epidemiological aspects and prevention strategy of hepatitis B and C viral infections in children with cancer. Pediatr J Infect Dis J 2002; 20: 1042-9.
62. Lavanchy D. Global Epidemiology of hepatitis C. Who informal consultation with VHPB, Geneva, Switzerland, 13-14 May, 2002. http://www.vhpb.org/geneva2002/S3P1%201avanchy.ppt.
63. Ariamkina OL, Grigor'ev B, Fadeeva GE, et al. The diagnosis of hepatitis C viral infection in blood donors and patients. Zh Mikrobiol Epidemiol Immunobiol 1998; 1: 74-7.
64. Grob P. The hepatitis C virus. Viral Hepatitis Board 2002; 11: 2-3.
65. Haus R, Alloui C, Alain S, et al. Etude de faisabilité pour la création d'un observatoire national des sous-types du virus de l'hépatite C, novembre 2000-avril 2001. Bull Epidemiol Hebd 2002; 46: 231-4.
66. Sampietro M, Badalamenti S, Salvadori S, et al. Hight prevalence of a rare hepatitis virus in patients treated in the same haemodialysis unit: evidence for nosocomial transmission. Kydney Int 1995; 47: 911-7.
67. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A. Hepatitits C in a haemodialysis unit: molecular evidence for nosocomial transmission. J Clin Micobiol 1998; 36: 3040-3.
68. Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999; 29: 1596-601.